Cargando…

A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients

PURPOSE/BACKGROUND: Studies analyzing concentration-effect relationships in second-generation antipsychotics have reported contradictory results in chronic schizophrenia. No data are available for the early stages of the disease. The present study aims to evaluate the association between a single ol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zabala, Arantzazu, Bustillo, Mariana, Querejeta, Imanol, Alonso, Marta, Mentxaka, Oiane, González-Pinto, Ana, Ugarte, Amaia, Meana, J. Javier, Gutiérrez, Miguel, Segarra, Rafael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Original Contributions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596831/ https://www.ncbi.nlm.nih.gov/pubmed/28796022 http://dx.doi.org/10.1097/JCP.0000000000000770

Ejemplares similares

Violence in first-episode psychosis: evidence from an early intervention in psychosis programme
por: Mentxaka, Oihane, et al.
Publicado: (2023)

Violence and psychosis: Clinical evidences from an Early Intervention Program
por: Mentxaka, O., et al.
Publicado: (2023)

Oral and Palmitate Paliperidone Long-Acting Injectable Formulations’ Use in Schizophrenia Spectrum Disorders: A Retrospective Cohort Study from the First Episode Psychosis Intervention Program (CRUPEP)
por: Segarra, R, et al.
Publicado: (2021)

Early onset first episode psychosis: dimensional structure of symptoms, clinical subtypes and related neurodevelopmental markers
por: Petruzzelli, Maria Giuseppina, et al.
Publicado: (2017)

Effects of olanzapine on cytokine profile and brain-derived neurotrophic factor in drug-naive subjects with first-episode psychosis
por: Hatziagelaki, Erifili, et al.
Publicado: (2019)

Olanzapine and its use for methamphetamine-induced psychosis
por: Nazir, S., et al.
Publicado: (2022)

Weight Gain and Metabolic Changes in Patients With First-Episode Psychosis or Early-Phase Schizophrenia Treated With Olanzapine: A Meta-Analysis
por: Correll, Christoph U, et al.
Publicado: (2023)

Cognitive Enhancers in Schizophrenia: A Systematic Review and Meta-Analysis of Alpha-7 Nicotinic Acetylcholine Receptor Agonists for Cognitive Deficits and Negative Symptoms
por: Recio-Barbero, María, et al.
Publicado: (2021)

Effect of Miricorilant, a Selective Glucocorticoid Receptor Modulator, on Olanzapine-Associated Weight Gain in Healthy Subjects: A Proof-of-Concept Study
por: Hunt, Hazel J., et al.
Publicado: (2021)

A fixed-dose randomized controlled trial of olanzapine for psychosis in Parkinson disease
por: Nichols, Michelle J, et al.
Publicado: (2013)

Successful Treatment with Olanzapine of Psychosis in Dentatorubral-pallidoluysian Atrophy: A Case Report
por: Narita, Zui, et al.
Publicado: (2018)

Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders: A Secondary Outcome Analysis of a Pragmatic, Randomized Trial (BeSt InTro)
por: Kjelby, Eirik, et al.
Publicado: (2023)

Olanzapine induced DNA methylation changes support the dopamine hypothesis of psychosis
por: Melka, Melkaye G, et al.
Publicado: (2013)

Prescription Stimulant Use and Hospitalization for Psychosis or Mania: A Population-Based Study
por: Cressman, Alex M., et al.
Publicado: (2015)

Social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis
por: González-Ortega, I., et al.
Publicado: (2021)

Potential diagnostic markers of olanzapine efficiency for acute psychosis: a focus on peripheral biogenic amines
por: Taraskina, A. E., et al.
Publicado: (2017)

Olanzapine Versus Risperidone in Children and Adolescents with Psychosis: A Meta-Analysis of Randomized Controlled Trials
por: Xia, Lei, et al.
Publicado: (2018)

Determination of Olanzapine and N-desmethyl-olanzapine in Plasma Using a Reversed-Phase HPLC Coupled with Coulochemical Detection: Correlation of Olanzapine or N-desmethyl-olanzapine Concentration with Metabolic Parameters
por: Lu, Mong-Liang, et al.
Publicado: (2013)

Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone
por: Gómez-Revuelta, Marcos, et al.
Publicado: (2020)

Recurrent Episodes of Paraphilic Behavior Possibly Associated With Olanzapine and Aripiprazole Treatment in a Patient With Schizophrenia
por: Stefanou, Maria-Ioanna, et al.
Publicado: (2020)

An investigation of a genomewide supported psychosis variant in ZNF804A and white matter integrity in the human brain()
por: Sprooten, Emma, et al.
Publicado: (2012)

Olanzapine-induced methylation alters cadherin gene families and associated pathways implicated in psychosis
por: Melka, Melkaye G, et al.
Publicado: (2014)

Functional neuroimaging in first-episode psychosis
por: Gheorghe, Mihai D., et al.
Publicado: (2005)

Clinical Recovery in First-Episode Psychosis
por: Wunderink, Lex, et al.
Publicado: (2009)

Treatment Principles of First-Episode Psychosis
por: ÜÇOK, Alp
Publicado: (2021)

The Role of the Microbiome in First Episode of Psychosis
por: Nuncio-Mora, Lucero, et al.
Publicado: (2023)

Digital Psychoeducation for First Episode Psychosis
por: Ahmedani, Iman, et al.
Publicado: (2023)

The effect of early life events on glucose levels in first-episode psychosis
por: Garcia-Rizo, Clemente, et al.
Publicado: (2022)

ESCAP practice guidance for autism: a summary of evidence-based recommendations for diagnosis and treatment
por: Fuentes, Joaquin, et al.
Publicado: (2020)

Return to College After a First Episode of Psychosis
por: Shinn, Ann K, et al.
Publicado: (2020)

Role of migration in the development of a first episode of psychosis
por: Vaz, R., et al.
Publicado: (2022)

Cannabis and First-Episode Psychosis: Different Long-term Outcomes Depending on Continued or Discontinued Use
por: González-Pinto, Ana, et al.
Publicado: (2011)

Psychosis, vulnerability, and the moral significance of biomedical innovation in psychiatry. Why ethicists should join efforts
por: Corsico, Paolo
Publicado: (2019)

The right occipital lobe and poor insight in first-episode psychosis
por: Tordesillas-Gutierrez, Diana, et al.
Publicado: (2018)

One-Year Outcome and Adherence to Pharmacological Guidelines in First-Episode Schizophrenia: Results From a Consecutive Cohort Study
por: Drosos, Petros, et al.
Publicado: (2020)

Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia
por: An, Huimei, et al.
Publicado: (2022)

Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study
por: Johnsen, Erik, et al.
Publicado: (2013)

Effects of quetiapine and olanzapine in patients with psychosis and violent behavior: a pilot randomized, open-label, comparative study
por: Gobbi, Gabriella, et al.
Publicado: (2014)

Long-Term Grey Matter Changes in First Episode Psychosis: A Systematic Review
por: Gallardo-Ruiz, Ruth, et al.
Publicado: (2019)

Determination of psychosis-related clinical profiles in children with autism spectrum disorders using latent class analysis
por: Kyriakopoulos, Marinos, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_c4h4gnn8tvkj7cnst0u8hrdcmd